Actively Recruiting
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Led by CorEvitas · Updated on 2026-02-09
200
Participants Needed
1
Research Sites
3976 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
CONDITIONS
Official Title
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Generalized Pustular Psoriasis by a dermatologist or qualified dermatology practitioner
- At least 18 years of age and legally able to consent under applicable law
- Willing to provide consent for participation in the registry
- Willing to provide personal information for research purposes
You will not qualify if you...
- Currently participating or planning to participate in a blinded clinical trial evaluating a systemic agent for GPP
- Enrolled in another CorEvitas registry for a dermatological condition; must exit that registry to participate in this one
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CorEvitas, LLC
Waltham, Massachusetts, United States, 02451
Actively Recruiting
Research Team
C
Cathy Cheney
CONTACT
J
Jeffrey Greenberg, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here